ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1006

$1.21M Total Retail Price of All Prescriptions

Rank: 24 out of 1006

693 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 693 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 693 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,250 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 595 487 1 6
WARFARIN SODIUM 592 549 2 8
LISINOPRIL 466 375 3 3
OMEPRAZOLE 461 354 4 9
LEVOTHYROXINE SODIUM 413 361 5 2
SIMVASTATIN 411 334 6 1
AMLODIPINE BESYLATE 375 326 7 4
METOPROLOL TARTRATE 328 255 8 7
ESCITALOPRAM OXALATE 315 243 9 27
METFORMIN HCL 289 230 10 10
TRAZODONE HCL 283 243 11 21
HYDROCODONE-ACETAMINOPHEN 257 212 S3 12 25
GABAPENTIN 249 143 13 20
RISPERIDONE 231 95 14 40
PREDNISONE 217 183 15 33
TAMSULOSIN HCL 215 143 16 23
MIRTAZAPINE 201 193 17 26
ATORVASTATIN CALCIUM 199 169 18 5
PRAVASTATIN SODIUM 198 166 19 15
HYDROCHLOROTHIAZIDE 197 176 20 11
DIVALPROEX SODIUM 192 110 21 53
OXYCODONE-ACETAMINOPHEN 183 154 S2 22 57
POTASSIUM CHLORIDE 171 134 23 30
ZOLPIDEM TARTRATE 162 116 24 14
LANTUS 162 125 24 43
GLIMEPIRIDE 161 148 26 50
LEVETIRACETAM 153 69 27 72
DONEPEZIL HCL 153 153 27 17
CYMBALTA 149 92 29 41
ALENDRONATE SODIUM 135 110 30 29
PANTOPRAZOLE SODIUM 129 83 31 32
OXYCODONE HCL 128 49 S2 32 54
NEXIUM 125 70 33 28
IPRATROPIUM-ALBUTEROL 119 116 34 73
CITALOPRAM HBR 116 92 35 24
METOPROLOL SUCCINATE 115 80 36 12
LIDODERM 114 94 37 66
AZITHROMYCIN 112 91 38 39
CLOPIDOGREL 110 88 39 46
QUETIAPINE FUMARATE 100 87 40 45
ISOSORBIDE MONONITRATE ER 98 93 41 59
CARVEDILOL 97 68 42 36
PLAVIX 97 79 42 61
SERTRALINE HCL 97 74 42 19
ADVAIR DISKUS 95 80 45 37
LEXAPRO 91 69 46 103
SPIRIVA 89 85 47 48
PROAIR HFA 88 37 48 64
PAROXETINE HCL 87 56 49 62
DIOVAN 82 71 50 16
LEVOFLOXACIN 79 69 51 96
LACTULOSE 78 35 52 104
ATENOLOL 77 64 53 13
CARBIDOPA-LEVODOPA 76 74 54 80
ALLOPURINOL 76 65 54 31
EXELON 75 75 56 99
FENTANYL 74 39 S2 57 74
ALBUTEROL SULFATE 71 63 58 155
SINGULAIR 70 31 59 82
PHENYTOIN SODIUM EXTENDED 70 25 59 149
LAMOTRIGINE 68 40 61 119
CLOTRIMAZOLE-BETAMETHASONE 68 62 61 111
FLUOXETINE HCL 67 29 63 85
TRAMADOL HCL 67 51 63 35
SYNTHROID 66 60 65 42
ROPINIROLE HCL 66 53 65 154
OXYCONTIN 64 25 S2 67 98
RANITIDINE HCL 63 33 68 63
OLANZAPINE 62 62 69 68
TRIAMCINOLONE ACETONIDE 61 19 70 135
TRICOR 61 61 70 101
LIPITOR 60 54 72 47
DOXYCYCLINE HYCLATE 60 28 72 130
FINASTERIDE 59 39 74 76
BENICAR 58 55 75 78
DIOVAN HCT 57 57 76 60
AMIODARONE HCL 54 54 77 168
QUINAPRIL HCL 54 50 77 86
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 41 79 118
CRESTOR 51 45 80 18
ABILIFY 50 44 81 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.